AML-derived extracellular vesicles transmit immunomodulatory potential

Publikation: Beitrag in Fachzeitschrift › Abstrakt (Zeitschrift) › Begutachtung

Originalsprache	Englisch
Seiten (von - bis)	A62-A62
Fachzeitschrift	HUMAN GENE THERAPY
Jahrgang	30
Ausgabenummer	11
Publikationsstatus	Veröffentlicht - 2019
Veranstaltung	ESGCT 27th Annual Congress in collaboration with SETGyc Meeting - Barcelona, SPAIN Dauer: 22 Okt. 2019 → 25 Okt. 2019

Dieses zitieren

@article{fe956a5f1cd74184bb2eb5f1f6907d0d,

title = "AML-derived extracellular vesicles transmit immunomodulatory potential",

author = "B Vari and Martin Wolf and Anna Raninger and HM Binder and E Eminger and Dirk Strunk",

year = "2019",

language = "English",

volume = "30",

pages = "A62--A62",

journal = "HUMAN GENE THERAPY ",

issn = "1043-0342",

publisher = "Mary Ann Liebert, Inc. ",

number = "11",

note = "ESGCT 27th Annual Congress in collaboration with SETGyc Meeting ; Conference date: 22-10-2019 Through 25-10-2019",

}

Publikation: Beitrag in Fachzeitschrift › Abstrakt (Zeitschrift) › Begutachtung

TY - JOUR

T1 - AML-derived extracellular vesicles transmit immunomodulatory potential

AU - Vari, B

AU - Wolf, Martin

AU - Raninger, Anna

AU - Binder, HM

AU - Eminger, E

AU - Strunk, Dirk

PY - 2019

Y1 - 2019

M3 - Abstract (Journal)

SN - 1043-0342

VL - 30

SP - A62-A62

JO - HUMAN GENE THERAPY

JF - HUMAN GENE THERAPY

IS - 11

T2 - ESGCT 27th Annual Congress in collaboration with SETGyc Meeting

Y2 - 22 October 2019 through 25 October 2019

ER -